CL2014000357A1 - Compuesto acido (3s)-3-[4-[[5-[(8-metoxi-3,4-dihidro-2h-quinolin-1-il)metil]-2-tienil]metoxi]fenil]hex-4-inoico; metodo para prepararlo; composicion farmaceutica que lo comprende; compuesto intermediario; y su uso para tratar diabetes. - Google Patents
Compuesto acido (3s)-3-[4-[[5-[(8-metoxi-3,4-dihidro-2h-quinolin-1-il)metil]-2-tienil]metoxi]fenil]hex-4-inoico; metodo para prepararlo; composicion farmaceutica que lo comprende; compuesto intermediario; y su uso para tratar diabetes.Info
- Publication number
- CL2014000357A1 CL2014000357A1 CL2014000357A CL2014000357A CL2014000357A1 CL 2014000357 A1 CL2014000357 A1 CL 2014000357A1 CL 2014000357 A CL2014000357 A CL 2014000357A CL 2014000357 A CL2014000357 A CL 2014000357A CL 2014000357 A1 CL2014000357 A1 CL 2014000357A1
- Authority
- CL
- Chile
- Prior art keywords
- methoxy
- quinolin
- hex
- thienyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161524462P | 2011-08-17 | 2011-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2014000357A1 true CL2014000357A1 (es) | 2014-09-05 |
Family
ID=46690732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2014000357A CL2014000357A1 (es) | 2011-08-17 | 2014-02-13 | Compuesto acido (3s)-3-[4-[[5-[(8-metoxi-3,4-dihidro-2h-quinolin-1-il)metil]-2-tienil]metoxi]fenil]hex-4-inoico; metodo para prepararlo; composicion farmaceutica que lo comprende; compuesto intermediario; y su uso para tratar diabetes. |
Country Status (29)
Country | Link |
---|---|
US (1) | US8431706B2 (es) |
EP (1) | EP2744806B1 (es) |
JP (1) | JP5903162B2 (es) |
KR (1) | KR101570624B1 (es) |
CN (1) | CN103687856B (es) |
AP (1) | AP3589A (es) |
AR (1) | AR087451A1 (es) |
AU (1) | AU2012295372A1 (es) |
BR (1) | BR112014003079A2 (es) |
CA (1) | CA2843474C (es) |
CL (1) | CL2014000357A1 (es) |
CO (1) | CO6880069A2 (es) |
CR (1) | CR20140052A (es) |
DO (1) | DOP2014000018A (es) |
EA (1) | EA022165B1 (es) |
EC (1) | ECSP14013211A (es) |
ES (1) | ES2578165T3 (es) |
GT (1) | GT201400022A (es) |
IL (1) | IL230635A (es) |
IN (1) | IN2014MN00191A (es) |
MA (1) | MA35351B1 (es) |
MX (1) | MX2014001832A (es) |
PE (1) | PE20140831A1 (es) |
SG (1) | SG11201401793PA (es) |
TN (1) | TN2014000058A1 (es) |
TW (1) | TWI537262B (es) |
UA (1) | UA110983C2 (es) |
WO (1) | WO2013025424A1 (es) |
ZA (1) | ZA201400705B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105722841A (zh) | 2013-11-14 | 2016-06-29 | 卡迪拉保健有限公司 | 新型杂环化合物 |
US9957219B2 (en) | 2013-12-04 | 2018-05-01 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
EP3102198B1 (en) | 2014-02-06 | 2020-08-26 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
CN109666027A (zh) * | 2017-10-17 | 2019-04-23 | 中国科学院上海药物研究所 | 一类酰胺结构的gpr40激动剂化合物及其用途 |
US11964938B2 (en) | 2018-01-08 | 2024-04-23 | Celon Pharma S.A. | 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists |
TWI796596B (zh) | 2018-02-13 | 2023-03-21 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
JP7242702B2 (ja) | 2018-04-19 | 2023-03-20 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
EP4234030A3 (en) | 2018-07-13 | 2023-10-18 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
CN112955435A (zh) | 2018-10-24 | 2021-06-11 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
TWI751585B (zh) * | 2019-06-28 | 2022-01-01 | 美商美國禮來大藥廠 | 類升糖素肽1受體促效劑 |
WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
MX2022014505A (es) | 2020-05-19 | 2022-12-13 | Kallyope Inc | Activadores de la ampk. |
JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ,インク. | Ampkアクチベーター |
KR20220136800A (ko) * | 2021-04-01 | 2022-10-11 | 현대약품 주식회사 | 3-(4-(벤질옥시)페닐)헥스-4-이노익산 유도체의 신규 용도 |
CN115317484B (zh) * | 2022-08-26 | 2023-07-18 | 北京箭牧科技有限公司 | Ly2922470在制备预防或治疗脑血管疾病或组织缺血再灌注损伤药物中的应用 |
CN115671105B (zh) * | 2022-11-22 | 2023-10-27 | 北京箭牧科技有限公司 | Ly2922470在制备预防或治疗肾脏疾病药物中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
GT199900147A (es) * | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
NZ527276A (en) * | 2001-03-27 | 2004-11-26 | Actelion Pharmaceuticals Ltd | 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists |
AU2005220728B2 (en) * | 2004-02-27 | 2009-08-06 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
EP1726580A4 (en) * | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
WO2005095338A1 (ja) * | 2004-03-30 | 2005-10-13 | Takeda Pharmaceutical Company Limited | アルコキシフェニルプロパン酸誘導体 |
AR078522A1 (es) | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
AR078948A1 (es) | 2009-11-30 | 2011-12-14 | Lilly Co Eli | Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes |
-
2012
- 2012-08-03 TW TW101128102A patent/TWI537262B/zh not_active IP Right Cessation
- 2012-08-03 AR ARP120102845A patent/AR087451A1/es unknown
- 2012-08-09 EP EP12748334.5A patent/EP2744806B1/en active Active
- 2012-08-09 MX MX2014001832A patent/MX2014001832A/es unknown
- 2012-08-09 EA EA201490269A patent/EA022165B1/ru not_active IP Right Cessation
- 2012-08-09 ES ES12748334.5T patent/ES2578165T3/es active Active
- 2012-08-09 BR BR112014003079A patent/BR112014003079A2/pt not_active IP Right Cessation
- 2012-08-09 CN CN201280036072.0A patent/CN103687856B/zh active Active
- 2012-08-09 KR KR1020147003634A patent/KR101570624B1/ko not_active IP Right Cessation
- 2012-08-09 AP AP2014007436A patent/AP3589A/xx active
- 2012-08-09 JP JP2014526078A patent/JP5903162B2/ja active Active
- 2012-08-09 WO PCT/US2012/050051 patent/WO2013025424A1/en active Application Filing
- 2012-08-09 US US13/570,342 patent/US8431706B2/en active Active
- 2012-08-09 AU AU2012295372A patent/AU2012295372A1/en not_active Abandoned
- 2012-08-09 UA UAA201401073A patent/UA110983C2/uk unknown
- 2012-08-09 SG SG11201401793PA patent/SG11201401793PA/en unknown
- 2012-08-09 PE PE2014000218A patent/PE20140831A1/es not_active Application Discontinuation
- 2012-08-09 CA CA2843474A patent/CA2843474C/en not_active Expired - Fee Related
-
2013
- 2013-01-30 CR CR20140052A patent/CR20140052A/es unknown
-
2014
- 2014-01-23 IL IL230635A patent/IL230635A/en not_active IP Right Cessation
- 2014-01-28 DO DO2014000018A patent/DOP2014000018A/es unknown
- 2014-01-29 ZA ZA2014/00705A patent/ZA201400705B/en unknown
- 2014-01-30 IN IN191MUN2014 patent/IN2014MN00191A/en unknown
- 2014-02-10 TN TNP2014000058A patent/TN2014000058A1/en unknown
- 2014-02-13 GT GT201400022A patent/GT201400022A/es unknown
- 2014-02-13 CL CL2014000357A patent/CL2014000357A1/es unknown
- 2014-02-13 MA MA36755A patent/MA35351B1/fr unknown
- 2014-02-14 CO CO14032116A patent/CO6880069A2/es active IP Right Grant
- 2014-02-17 EC ECSP14013211 patent/ECSP14013211A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014000357A1 (es) | Compuesto acido (3s)-3-[4-[[5-[(8-metoxi-3,4-dihidro-2h-quinolin-1-il)metil]-2-tienil]metoxi]fenil]hex-4-inoico; metodo para prepararlo; composicion farmaceutica que lo comprende; compuesto intermediario; y su uso para tratar diabetes. | |
CL2014000919A1 (es) | Compuestos derivados de acido 2-tert-butoxi-2-(5-metilbenzo[d]tiazol-6-il) acetico; composicion farmaceutica que los comprende; metodo para tratar una infeccion por vih; y su uso para tratar una infeccion por vih. | |
TWI799757B (zh) | 抗-α4β7抗體之調配物 | |
EP2769976B8 (en) | Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof | |
BR112013030163A2 (pt) | composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto. | |
CL2014002904A1 (es) | Una composición geopolimérica de aluminosilicato; metodo de preparacion. | |
BR112012005853A2 (pt) | aplicador automático para preparações farmacêuticas líquidas, particularmente para insulina | |
BR112014015294A2 (pt) | método cosmétido; de referência de cor, especialmente para implementar método; sistema para implementar o metodo, pacote de software de computador para implementar o método | |
BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
BR112013014692A2 (pt) | composto e respectivo processo de preparação e composição farmacêutica | |
BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112014007134A2 (pt) | usos de um composto da fórmula (b), compostos, composição farmacêutica, método de preparação do composto e uso de uma quantidade efetiva de um composto | |
CL2013003129A1 (es) | Composicion herbicida de emulsión de aceite en agua, estable de alta resistencia; metodo para preparar dicha composicion. | |
BR112013010692A2 (pt) | interface de compartilhamento de conteúdo para compartilhamento de conteúdo em redes sociais | |
BR112013023174A2 (pt) | "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos" | |
BR112014010179A8 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
BR112014007645A2 (pt) | composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica | |
BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
CL2014000470A1 (es) | Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana. | |
BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BR112013033464A2 (pt) | composto, acetato, composição farmacêutica, combinação farmacêutica, método e método melhorado | |
BR112014009950A2 (pt) | composto dissubstituído, compostos e composição farmacêutica | |
BR112014001274A2 (pt) | composto de hormônio luteinizante, e, composição farmacêutica | |
BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
BR112012023355A2 (pt) | composto, composição farmacêutica e método de ruptura da interação nek2/hec1 |